Statin use vs. average non-HDL cholesterol levels in New Zealand
New Zealand: Statin use vs. average non-HDL cholesterol levels was 3.4 in 2018. ▼ Falling
Statin use vs. average non-HDL cholesterol levels in New Zealand, 1980–2018
Source: World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.
Analysis
New Zealand recorded 3.4 for statin use vs. average non-hdl cholesterol levels in 2018. That is the lowest value across all 39 years on record.
That represents a change of down 10.5% over ten years.
Over the whole period, statin use vs. average non-hdl cholesterol levels in New Zealand peaked at 4.5 in 1980 and was at its lowest, 3.4, in 2016.
That places New Zealand 75th out of 191 countries with data for 2018, putting it in the middle of the range.
The long-run direction has been consistently falling across the 39 years of available data.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1980s | 4.48 | 4.4 | 4.5 | 10 |
| 1990s | 4.31 | 4.2 | 4.4 | 10 |
| 2000s | 3.92 | 3.7 | 4.1 | 10 |
| 2010s | 3.53 | 3.4 | 3.7 | 9 |
Countries ranked near New Zealand
- 75 Argentina 3.4 compare
- 75 Belize 3.4 compare
- 75 Brazil 3.4 compare
- 75 Chile 3.4 compare
- 75 Germany 3.4 compare
- 75 Israel 3.4 compare
- 75 Japan 3.4 compare
- 75 Nicaragua 3.4 compare
- 75 Niue 3.4 compare
- 75 North Korea 3.4 compare
- 75 Oman 3.4 compare
- 75 Peru 3.4 compare
- 75 Saudi Arabia 3.4 compare
- 75 South Korea 3.4 compare
- 75 Sweden 3.4 compare
- 75 Switzerland 3.4 compare
- 75 Syria 3.4 compare
- 75 Tuvalu 3.4 compare
- 75 Yemen 3.4 compare
More reference data data for New Zealand
- Summer temperature anomalies 1.76 °C (2026)
- Temperature anomalies by month 0.0464 °C (2026)
- Spring temperature anomalies 0.2008 °C (2026)
- Winter temperature anomalies 0.5536 °C (2025)
- Universal right to vote in practice 2 (2025)
- Consumer price index 144.86 2010 = 100 (2025)
- Autumn temperature anomalies 0.5251 °C (2025)
- Democracy 7 (2025)
- Free country 2 (2025)
- Civil liberties rating 1 (2025)
Frequently asked questions
- What is statin use vs. average non-hdl cholesterol levels in New Zealand?
- Statin use vs. average non-hdl cholesterol levels in New Zealand was 3.4 in 2018, according to World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data.
- What is the highest statin use vs. average non-hdl cholesterol levels recorded in New Zealand?
- The highest recorded value was 4.5 in 1980.
- What is the lowest statin use vs. average non-hdl cholesterol levels recorded in New Zealand?
- The lowest recorded value was 3.4 in 2016.
- How does New Zealand rank for statin use vs. average non-hdl cholesterol levels?
- New Zealand ranks 75th out of 191 countries with data for 2018.
- Is statin use vs. average non-hdl cholesterol levels rising or falling in New Zealand?
- Over the last ten years it is down 10.5%. The long-run trend across the full record is falling.
- Where does this New Zealand data come from?
- The figures come from World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as part of Statin use vs. average non-HDL cholesterol levels. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 39 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.